semaglutide gastroparesis lawsuit 2024 Ozempic carries an FDA black box warning for medullary thyroid carcinoma. Over 1,800 lawsuits are consolidated in federal MDL litigation with >$2 billion projected liability — primarily for gastroparesis, intestinal blockage, gallbladder Ozempic on Trial: A New

We will work with you to identify, understand, and manage behaviors that may impact your well-being and weight management

Peptide treatments are minimally invasive and are administered via subcutaneous injection with a thin needle or through topical creams

et al: Cardioprotective Glucose-Lowering Agents and Dementia Risk: A Systematic Review and Meta-Analysis. JAMA Neurology, April 7, 2025 Hullin Tang, PhD

These genetic markers can indicate how your body may respond to GLP-1 therapy and which formulationinjection or oral semaglutidemight work best for you

Experiments were approved by the Ethics Committee for Animal Experimentation (CEUA) of the State University of Maring